Pragmatic Trials for Noncommunicable Diseases: Relieving Constraints
Open Access
- 29 March 2016
- journal article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 13 (3), e1001986
- https://doi.org/10.1371/journal.pmed.1001986
Abstract
In this month's editorial, PLOS Medicine Editorial Board member Anushka Patel and Ruth Webster discuss how applying rules for drug efficacy trials can impede pragmatic trials of interventions for noncommunicable diseases.This publication has 4 references indexed in Scilit:
- Implementation research: what it is and how to do it.2013
- Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and EuropeEuropean Journal of Preventive Cardiology, 2012
- Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological surveyThe Lancet, 2011
- A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health OrganizationTrials, 2011